Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Carmellose sodium |
Is a |
False |
Carmellose |
Inferred relationship |
Some |
|
Carmellose adverse reaction |
Causative agent (attribute) |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Allergy to carmellose |
Causative agent (attribute) |
False |
Carmellose |
Inferred relationship |
Some |
|
Carboxymethylcellulose sodium 16.58% oral paste |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose |
Inferred relationship |
Some |
|
Carboxymethylcellulose sodium powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose |
Inferred relationship |
Some |
|
Product containing carmellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Carmellose sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose |
Inferred relationship |
Some |
|
Carmellose sodium [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose |
Inferred relationship |
Some |
|
Carmellose sodium 1% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose |
Inferred relationship |
Some |
|
Product containing carmellose sodium in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose |
Inferred relationship |
Some |
|
Product containing carmellose sodium in oropharyngeal dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose |
Inferred relationship |
Some |
|
Carmellose sodium 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose |
Inferred relationship |
Some |
|
Allergy to carmellose |
Causative agent (attribute) |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Carmellose sodium |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Carmellose |
Inferred relationship |
Some |
|
Carmellose sodium 1% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose |
Inferred relationship |
Some |
|
Product containing only calcium phosphate and carmellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Product containing only carmellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Product containing precisely carmellose 166 milligram/1 gram conventional release oral paste (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Carmellose |
Inferred relationship |
Some |
1 |
Product containing precisely carmellose 166 milligram/1 gram conventional release oral paste (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Carmellose |
Inferred relationship |
Some |
1 |
Product containing calcium phosphate and carmellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Calcium phosphate and carmellose only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Carmellose- and hydroxyapatite-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Carmellose only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Product containing only carmellose in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Carmellose-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Carmellose-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Carmellose- and hydroxyapatite-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Carmellose and hydroxyapatite only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Carmellose and hydroxyapatite only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Product containing calcium phosphate and carmellose in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Carmellose 166 mg/g oromucosal paste |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Carmellose 166 mg/g oromucosal paste |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Product containing carmellose in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |
Carmellose only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmellose |
Inferred relationship |
Some |
1 |